Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
ResMed Inc. (RMD)
Market Closed
17 Jul, 20:00
NYSE
All
(10)
DE
(5)
AT
(1)
IT
(1)
MX
(1)
GB
(1)
US
(1)
NYSE
Primary
LSE
XSTU
XMUN
XDUS
XMEX
XHAN
XWBO
XFRA
XMIL
$
198.
99
-3.77
-1.8593%
$
28.86B
Market Cap
27.49
P/E Ratio
2.1%
Div Yield
1.28M
Volume
6.52
Eps
$
202.76
Previous Close
Investors:
TJD
DI
TMB
LC
CE
+215
Analysts:
DL
Watching
Watch
Add Transaction
Day Range
198.22
203.04
Year Range
180.27
293.81
Want to track
RMD
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
News
Historical Data
Investors
Analysts
ResMed Inc. (RMD) Statistics
Valuation metrics
Market Cap
28.86B
Enterprise value
28.05B
Trailing P/E (ttm)
19.17
Forward P/E
16.86
PEG ratio
1.2
Price/Sales (ttm)
5.21
Price/Book (mrq)
4.49
Enterprise Value/Revenue
5.06
Enterprise Value/EBITDA
12.83
Overview
Shares outstanding
145.68M
Float
144.79M
Shares short
11.49M
% Held by insiders
0.01%
% Held by institutions
0.69%
Average volume (10 days)
1.19M
Average volume (90 days)
1.4M
Price summary
52-Week low
180.27
52-Week high
293.81
Beta
0.93
50-Day moving average
198.03
200-Day moving average
232.86
Dividends and splits
Forward annual dividend rate
2.4
Forward annual dividend yield
0.0117%
Trailing annual dividend rate
2.4
Trailing annual dividend yield
0.0121%
5-Year annual dividend yield
0.84%
Payout ratio
0.22
Dividend Date
18 Jun 2026
Ex-Dividend Date
14 May 2026
Last split factor
2:1
Last split Date
31 Aug 2010
Financials
Fiscal year
Fiscal year ends
30 Jun 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.27%
Operating margin
0.34%
Operational effectiveness
Return on assets
0.17%
Return on equity
0.24%
Income Statement
Revenue (ttm)
5.4B
Revenue per share (ttm)
37.81
Quarterly revenue growth (yoy)
0.11%
Gross profit (ttm)
3.32B
EBITDA
1.93B
Net income to common (ttm)
1.49B
Diluted EPS (ttm)
10.37
Quarterly earnings growth (yoy)
0.14%
Balance Sheet
Total cash (mrq)
1.42B
Total cash per share (mrq)
11.37
Total debt (mrq)
847.72M
Total Debt/Equity (mrq)
0.13
Current ratio (mrq)
3.01%
Book value per share (mrq)
44.32
Cash Flow
Cash flow statement
1.91B
Levered free cash flow (LFCF)
1.42B